The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Inactivated Hepatitis A Vaccine Market Research Report 2025
Synopsis
Inactivated Hepatitis A Vaccine is a type of vaccine designed to protect against the Hepatitis A virus. Hepatitis A is a viral infection that primarily affects the liver and is usually spread through contaminated food or water. The inactivated Hepatitis A vaccine is a preventive measure that helps the immune system recognize and fight the virus.
The global Inactivated Hepatitis A Vaccine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Inactivated Hepatitis A Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Inactivated Hepatitis A Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Inactivated Hepatitis A Vaccine include Hualan Vaccine, SINOVAC, GSK, Merck, Sanofi, KM Biologics, IMBCAMS, AIM Vaccine and AIM Action, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Inactivated Hepatitis A Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Inactivated Hepatitis A Vaccine.
Report Scope
The Inactivated Hepatitis A Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Inactivated Hepatitis A Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Inactivated Hepatitis A Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Hualan Vaccine
SINOVAC
GSK
Merck
Sanofi
KM Biologics
IMBCAMS
AIM Vaccine
AIM Action
Segment by Type
1.0ml
0.5ml
Segment by Application
Hospital
Clinic
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
China Taiwan
Australia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Inactivated Hepatitis A Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Inactivated Hepatitis A Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Inactivated Hepatitis A Vaccine is a type of vaccine designed to protect against the Hepatitis A virus. Hepatitis A is a viral infection that primarily affects the liver and is usually spread through contaminated food or water. The inactivated Hepatitis A vaccine is a preventive measure that helps the immune system recognize and fight the virus.
The global Inactivated Hepatitis A Vaccine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Inactivated Hepatitis A Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Inactivated Hepatitis A Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Inactivated Hepatitis A Vaccine include Hualan Vaccine, SINOVAC, GSK, Merck, Sanofi, KM Biologics, IMBCAMS, AIM Vaccine and AIM Action, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Inactivated Hepatitis A Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Inactivated Hepatitis A Vaccine.
Report Scope
The Inactivated Hepatitis A Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Inactivated Hepatitis A Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Inactivated Hepatitis A Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Hualan Vaccine
SINOVAC
GSK
Merck
Sanofi
KM Biologics
IMBCAMS
AIM Vaccine
AIM Action
Segment by Type
1.0ml
0.5ml
Segment by Application
Hospital
Clinic
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
China Taiwan
Australia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Inactivated Hepatitis A Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Inactivated Hepatitis A Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Inactivated Hepatitis A Vaccine Market Overview
1.1 Product Overview and Scope of Inactivated Hepatitis A Vaccine
1.2 Inactivated Hepatitis A Vaccine Segment by Type
1.2.1 Global Inactivated Hepatitis A Vaccine Market Value Comparison by Type (2024-2030)
1.2.2 1.0ml
1.2.3 0.5ml
1.3 Inactivated Hepatitis A Vaccine Segment by Application
1.3.1 Global Inactivated Hepatitis A Vaccine Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Inactivated Hepatitis A Vaccine Market Size Estimates and Forecasts
1.4.1 Global Inactivated Hepatitis A Vaccine Revenue 2019-2030
1.4.2 Global Inactivated Hepatitis A Vaccine Sales 2019-2030
1.4.3 Global Inactivated Hepatitis A Vaccine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Inactivated Hepatitis A Vaccine Market Competition by Manufacturers
2.1 Global Inactivated Hepatitis A Vaccine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Inactivated Hepatitis A Vaccine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Inactivated Hepatitis A Vaccine Average Price by Manufacturers (2019-2024)
2.4 Global Inactivated Hepatitis A Vaccine Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Inactivated Hepatitis A Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Inactivated Hepatitis A Vaccine, Product Type & Application
2.7 Inactivated Hepatitis A Vaccine Market Competitive Situation and Trends
2.7.1 Inactivated Hepatitis A Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Inactivated Hepatitis A Vaccine Players Market Share by Revenue
2.7.3 Global Inactivated Hepatitis A Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Inactivated Hepatitis A Vaccine Retrospective Market Scenario by Region
3.1 Global Inactivated Hepatitis A Vaccine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Inactivated Hepatitis A Vaccine Global Inactivated Hepatitis A Vaccine Sales by Region: 2019-2030
3.2.1 Global Inactivated Hepatitis A Vaccine Sales by Region: 2019-2024
3.2.2 Global Inactivated Hepatitis A Vaccine Sales by Region: 2025-2030
3.3 Global Inactivated Hepatitis A Vaccine Global Inactivated Hepatitis A Vaccine Revenue by Region: 2019-2030
3.3.1 Global Inactivated Hepatitis A Vaccine Revenue by Region: 2019-2024
3.3.2 Global Inactivated Hepatitis A Vaccine Revenue by Region: 2025-2030
3.4 North America Inactivated Hepatitis A Vaccine Market Facts & Figures by Country
3.4.1 North America Inactivated Hepatitis A Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Inactivated Hepatitis A Vaccine Sales by Country (2019-2030)
3.4.3 North America Inactivated Hepatitis A Vaccine Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Inactivated Hepatitis A Vaccine Market Facts & Figures by Country
3.5.1 Europe Inactivated Hepatitis A Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Inactivated Hepatitis A Vaccine Sales by Country (2019-2030)
3.5.3 Europe Inactivated Hepatitis A Vaccine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Netherlands
3.6 Asia Pacific Inactivated Hepatitis A Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Inactivated Hepatitis A Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Inactivated Hepatitis A Vaccine Sales by Country (2019-2030)
3.6.3 Asia Pacific Inactivated Hepatitis A Vaccine Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Southeast Asia
3.6.9 China Taiwan
3.6.10 Australia
3.7 Latin America Inactivated Hepatitis A Vaccine Market Facts & Figures by Country
3.7.1 Latin America Inactivated Hepatitis A Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Inactivated Hepatitis A Vaccine Sales by Country (2019-2030)
3.7.3 Latin America Inactivated Hepatitis A Vaccine Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Inactivated Hepatitis A Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Inactivated Hepatitis A Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Inactivated Hepatitis A Vaccine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Inactivated Hepatitis A Vaccine Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Inactivated Hepatitis A Vaccine Sales by Type (2019-2030)
4.1.1 Global Inactivated Hepatitis A Vaccine Sales by Type (2019-2024)
4.1.2 Global Inactivated Hepatitis A Vaccine Sales by Type (2025-2030)
4.1.3 Global Inactivated Hepatitis A Vaccine Sales Market Share by Type (2019-2030)
4.2 Global Inactivated Hepatitis A Vaccine Revenue by Type (2019-2030)
4.2.1 Global Inactivated Hepatitis A Vaccine Revenue by Type (2019-2024)
4.2.2 Global Inactivated Hepatitis A Vaccine Revenue by Type (2025-2030)
4.2.3 Global Inactivated Hepatitis A Vaccine Revenue Market Share by Type (2019-2030)
4.3 Global Inactivated Hepatitis A Vaccine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Inactivated Hepatitis A Vaccine Sales by Application (2019-2030)
5.1.1 Global Inactivated Hepatitis A Vaccine Sales by Application (2019-2024)
5.1.2 Global Inactivated Hepatitis A Vaccine Sales by Application (2025-2030)
5.1.3 Global Inactivated Hepatitis A Vaccine Sales Market Share by Application (2019-2030)
5.2 Global Inactivated Hepatitis A Vaccine Revenue by Application (2019-2030)
5.2.1 Global Inactivated Hepatitis A Vaccine Revenue by Application (2019-2024)
5.2.2 Global Inactivated Hepatitis A Vaccine Revenue by Application (2025-2030)
5.2.3 Global Inactivated Hepatitis A Vaccine Revenue Market Share by Application (2019-2030)
5.3 Global Inactivated Hepatitis A Vaccine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Hualan Vaccine
6.1.1 Hualan Vaccine Corporation Information
6.1.2 Hualan Vaccine Description and Business Overview
6.1.3 Hualan Vaccine Inactivated Hepatitis A Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Hualan Vaccine Inactivated Hepatitis A Vaccine Product Portfolio
6.1.5 Hualan Vaccine Recent Developments/Updates
6.2 SINOVAC
6.2.1 SINOVAC Corporation Information
6.2.2 SINOVAC Description and Business Overview
6.2.3 SINOVAC Inactivated Hepatitis A Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 SINOVAC Inactivated Hepatitis A Vaccine Product Portfolio
6.2.5 SINOVAC Recent Developments/Updates
6.3 GSK
6.3.1 GSK Corporation Information
6.3.2 GSK Description and Business Overview
6.3.3 GSK Inactivated Hepatitis A Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 GSK Inactivated Hepatitis A Vaccine Product Portfolio
6.3.5 GSK Recent Developments/Updates
6.4 Merck
6.4.1 Merck Corporation Information
6.4.2 Merck Description and Business Overview
6.4.3 Merck Inactivated Hepatitis A Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Merck Inactivated Hepatitis A Vaccine Product Portfolio
6.4.5 Merck Recent Developments/Updates
6.5 Sanofi
6.5.1 Sanofi Corporation Information
6.5.2 Sanofi Description and Business Overview
6.5.3 Sanofi Inactivated Hepatitis A Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Sanofi Inactivated Hepatitis A Vaccine Product Portfolio
6.5.5 Sanofi Recent Developments/Updates
6.6 KM Biologics
6.6.1 KM Biologics Corporation Information
6.6.2 KM Biologics Description and Business Overview
6.6.3 KM Biologics Inactivated Hepatitis A Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 KM Biologics Inactivated Hepatitis A Vaccine Product Portfolio
6.6.5 KM Biologics Recent Developments/Updates
6.7 IMBCAMS
6.6.1 IMBCAMS Corporation Information
6.6.2 IMBCAMS Description and Business Overview
6.6.3 IMBCAMS Inactivated Hepatitis A Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 IMBCAMS Inactivated Hepatitis A Vaccine Product Portfolio
6.7.5 IMBCAMS Recent Developments/Updates
6.8 AIM Vaccine
6.8.1 AIM Vaccine Corporation Information
6.8.2 AIM Vaccine Description and Business Overview
6.8.3 AIM Vaccine Inactivated Hepatitis A Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.8.4 AIM Vaccine Inactivated Hepatitis A Vaccine Product Portfolio
6.8.5 AIM Vaccine Recent Developments/Updates
6.9 AIM Action
6.9.1 AIM Action Corporation Information
6.9.2 AIM Action Description and Business Overview
6.9.3 AIM Action Inactivated Hepatitis A Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.9.4 AIM Action Inactivated Hepatitis A Vaccine Product Portfolio
6.9.5 AIM Action Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Inactivated Hepatitis A Vaccine Industry Chain Analysis
7.2 Inactivated Hepatitis A Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Inactivated Hepatitis A Vaccine Production Mode & Process
7.4 Inactivated Hepatitis A Vaccine Sales and Marketing
7.4.1 Inactivated Hepatitis A Vaccine Sales Channels
7.4.2 Inactivated Hepatitis A Vaccine Distributors
7.5 Inactivated Hepatitis A Vaccine Customers
8 Inactivated Hepatitis A Vaccine Market Dynamics
8.1 Inactivated Hepatitis A Vaccine Industry Trends
8.2 Inactivated Hepatitis A Vaccine Market Drivers
8.3 Inactivated Hepatitis A Vaccine Market Challenges
8.4 Inactivated Hepatitis A Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Inactivated Hepatitis A Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Inactivated Hepatitis A Vaccine Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Inactivated Hepatitis A Vaccine Market Competitive Situation by Manufacturers in 2023
Table 4. Global Inactivated Hepatitis A Vaccine Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Inactivated Hepatitis A Vaccine Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Inactivated Hepatitis A Vaccine Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Inactivated Hepatitis A Vaccine Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Inactivated Hepatitis A Vaccine Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Inactivated Hepatitis A Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Inactivated Hepatitis A Vaccine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Inactivated Hepatitis A Vaccine, Product Type & Application
Table 12. Global Key Manufacturers of Inactivated Hepatitis A Vaccine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Inactivated Hepatitis A Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inactivated Hepatitis A Vaccine as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Inactivated Hepatitis A Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Inactivated Hepatitis A Vaccine Sales by Region (2019-2024) & (K Units)
Table 18. Global Inactivated Hepatitis A Vaccine Sales Market Share by Region (2019-2024)
Table 19. Global Inactivated Hepatitis A Vaccine Sales by Region (2025-2030) & (K Units)
Table 20. Global Inactivated Hepatitis A Vaccine Sales Market Share by Region (2025-2030)
Table 21. Global Inactivated Hepatitis A Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Inactivated Hepatitis A Vaccine Revenue Market Share by Region (2019-2024)
Table 23. Global Inactivated Hepatitis A Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Inactivated Hepatitis A Vaccine Revenue Market Share by Region (2025-2030)
Table 25. North America Inactivated Hepatitis A Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Inactivated Hepatitis A Vaccine Sales by Country (2019-2024) & (K Units)
Table 27. North America Inactivated Hepatitis A Vaccine Sales by Country (2025-2030) & (K Units)
Table 28. North America Inactivated Hepatitis A Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Inactivated Hepatitis A Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Inactivated Hepatitis A Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Inactivated Hepatitis A Vaccine Sales by Country (2019-2024) & (K Units)
Table 32. Europe Inactivated Hepatitis A Vaccine Sales by Country (2025-2030) & (K Units)
Table 33. Europe Inactivated Hepatitis A Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Inactivated Hepatitis A Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Inactivated Hepatitis A Vaccine Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Inactivated Hepatitis A Vaccine Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Inactivated Hepatitis A Vaccine Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Inactivated Hepatitis A Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Inactivated Hepatitis A Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Inactivated Hepatitis A Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Inactivated Hepatitis A Vaccine Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Inactivated Hepatitis A Vaccine Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Inactivated Hepatitis A Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Inactivated Hepatitis A Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Inactivated Hepatitis A Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Inactivated Hepatitis A Vaccine Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Inactivated Hepatitis A Vaccine Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Inactivated Hepatitis A Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Inactivated Hepatitis A Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Inactivated Hepatitis A Vaccine Sales (K Units) by Type (2019-2024)
Table 51. Global Inactivated Hepatitis A Vaccine Sales (K Units) by Type (2025-2030)
Table 52. Global Inactivated Hepatitis A Vaccine Sales Market Share by Type (2019-2024)
Table 53. Global Inactivated Hepatitis A Vaccine Sales Market Share by Type (2025-2030)
Table 54. Global Inactivated Hepatitis A Vaccine Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Inactivated Hepatitis A Vaccine Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Inactivated Hepatitis A Vaccine Revenue Market Share by Type (2019-2024)
Table 57. Global Inactivated Hepatitis A Vaccine Revenue Market Share by Type (2025-2030)
Table 58. Global Inactivated Hepatitis A Vaccine Price (US$/Unit) by Type (2019-2024)
Table 59. Global Inactivated Hepatitis A Vaccine Price (US$/Unit) by Type (2025-2030)
Table 60. Global Inactivated Hepatitis A Vaccine Sales (K Units) by Application (2019-2024)
Table 61. Global Inactivated Hepatitis A Vaccine Sales (K Units) by Application (2025-2030)
Table 62. Global Inactivated Hepatitis A Vaccine Sales Market Share by Application (2019-2024)
Table 63. Global Inactivated Hepatitis A Vaccine Sales Market Share by Application (2025-2030)
Table 64. Global Inactivated Hepatitis A Vaccine Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Inactivated Hepatitis A Vaccine Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Inactivated Hepatitis A Vaccine Revenue Market Share by Application (2019-2024)
Table 67. Global Inactivated Hepatitis A Vaccine Revenue Market Share by Application (2025-2030)
Table 68. Global Inactivated Hepatitis A Vaccine Price (US$/Unit) by Application (2019-2024)
Table 69. Global Inactivated Hepatitis A Vaccine Price (US$/Unit) by Application (2025-2030)
Table 70. Hualan Vaccine Corporation Information
Table 71. Hualan Vaccine Description and Business Overview
Table 72. Hualan Vaccine Inactivated Hepatitis A Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Hualan Vaccine Inactivated Hepatitis A Vaccine Product
Table 74. Hualan Vaccine Recent Developments/Updates
Table 75. SINOVAC Corporation Information
Table 76. SINOVAC Description and Business Overview
Table 77. SINOVAC Inactivated Hepatitis A Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. SINOVAC Inactivated Hepatitis A Vaccine Product
Table 79. SINOVAC Recent Developments/Updates
Table 80. GSK Corporation Information
Table 81. GSK Description and Business Overview
Table 82. GSK Inactivated Hepatitis A Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. GSK Inactivated Hepatitis A Vaccine Product
Table 84. GSK Recent Developments/Updates
Table 85. Merck Corporation Information
Table 86. Merck Description and Business Overview
Table 87. Merck Inactivated Hepatitis A Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Merck Inactivated Hepatitis A Vaccine Product
Table 89. Merck Recent Developments/Updates
Table 90. Sanofi Corporation Information
Table 91. Sanofi Description and Business Overview
Table 92. Sanofi Inactivated Hepatitis A Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Sanofi Inactivated Hepatitis A Vaccine Product
Table 94. Sanofi Recent Developments/Updates
Table 95. KM Biologics Corporation Information
Table 96. KM Biologics Description and Business Overview
Table 97. KM Biologics Inactivated Hepatitis A Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. KM Biologics Inactivated Hepatitis A Vaccine Product
Table 99. KM Biologics Recent Developments/Updates
Table 100. IMBCAMS Corporation Information
Table 101. IMBCAMS Description and Business Overview
Table 102. IMBCAMS Inactivated Hepatitis A Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. IMBCAMS Inactivated Hepatitis A Vaccine Product
Table 104. IMBCAMS Recent Developments/Updates
Table 105. AIM Vaccine Corporation Information
Table 106. AIM Vaccine Description and Business Overview
Table 107. AIM Vaccine Inactivated Hepatitis A Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. AIM Vaccine Inactivated Hepatitis A Vaccine Product
Table 109. AIM Vaccine Recent Developments/Updates
Table 110. AIM Action Corporation Information
Table 111. AIM Action Description and Business Overview
Table 112. AIM Action Inactivated Hepatitis A Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. AIM Action Inactivated Hepatitis A Vaccine Product
Table 114. AIM Action Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Inactivated Hepatitis A Vaccine Distributors List
Table 118. Inactivated Hepatitis A Vaccine Customers List
Table 119. Inactivated Hepatitis A Vaccine Market Trends
Table 120. Inactivated Hepatitis A Vaccine Market Drivers
Table 121. Inactivated Hepatitis A Vaccine Market Challenges
Table 122. Inactivated Hepatitis A Vaccine Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Inactivated Hepatitis A Vaccine
Figure 2. Global Inactivated Hepatitis A Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Inactivated Hepatitis A Vaccine Market Share by Type in 2023 & 2030
Figure 4. 1.0ml Product Picture
Figure 5. 0.5ml Product Picture
Figure 6. Global Inactivated Hepatitis A Vaccine Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Inactivated Hepatitis A Vaccine Market Share by Application in 2023 & 2030
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Global Inactivated Hepatitis A Vaccine Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 11. Global Inactivated Hepatitis A Vaccine Market Size (2019-2030) & (US$ Million)
Figure 12. Global Inactivated Hepatitis A Vaccine Sales (2019-2030) & (K Units)
Figure 13. Global Inactivated Hepatitis A Vaccine Average Price (US$/Unit) & (2019-2030)
Figure 14. Inactivated Hepatitis A Vaccine Report Years Considered
Figure 15. Inactivated Hepatitis A Vaccine Sales Share by Manufacturers in 2023
Figure 16. Global Inactivated Hepatitis A Vaccine Revenue Share by Manufacturers in 2023
Figure 17. The Global 5 and 10 Largest Inactivated Hepatitis A Vaccine Players: Market Share by Revenue in 2023
Figure 18. Inactivated Hepatitis A Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 19. Global Inactivated Hepatitis A Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 20. North America Inactivated Hepatitis A Vaccine Sales Market Share by Country (2019-2030)
Figure 21. North America Inactivated Hepatitis A Vaccine Revenue Market Share by Country (2019-2030)
Figure 22. United States Inactivated Hepatitis A Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 23. Canada Inactivated Hepatitis A Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Europe Inactivated Hepatitis A Vaccine Sales Market Share by Country (2019-2030)
Figure 25. Europe Inactivated Hepatitis A Vaccine Revenue Market Share by Country (2019-2030)
Figure 26. Germany Inactivated Hepatitis A Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. France Inactivated Hepatitis A Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. U.K. Inactivated Hepatitis A Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Italy Inactivated Hepatitis A Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Netherlands Inactivated Hepatitis A Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Asia Pacific Inactivated Hepatitis A Vaccine Sales Market Share by Region (2019-2030)
Figure 32. Asia Pacific Inactivated Hepatitis A Vaccine Revenue Market Share by Region (2019-2030)
Figure 33. China Inactivated Hepatitis A Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Japan Inactivated Hepatitis A Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. South Korea Inactivated Hepatitis A Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. India Inactivated Hepatitis A Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Southeast Asia Inactivated Hepatitis A Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. China Taiwan Inactivated Hepatitis A Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia Inactivated Hepatitis A Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Latin America Inactivated Hepatitis A Vaccine Sales Market Share by Country (2019-2030)
Figure 41. Latin America Inactivated Hepatitis A Vaccine Revenue Market Share by Country (2019-2030)
Figure 42. Mexico Inactivated Hepatitis A Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Brazil Inactivated Hepatitis A Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Argentina Inactivated Hepatitis A Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Inactivated Hepatitis A Vaccine Sales Market Share by Country (2019-2030)
Figure 46. Middle East & Africa Inactivated Hepatitis A Vaccine Revenue Market Share by Country (2019-2030)
Figure 47. Turkey Inactivated Hepatitis A Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Saudi Arabia Inactivated Hepatitis A Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. UAE Inactivated Hepatitis A Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Global Sales Market Share of Inactivated Hepatitis A Vaccine by Type (2019-2030)
Figure 51. Global Revenue Market Share of Inactivated Hepatitis A Vaccine by Type (2019-2030)
Figure 52. Global Inactivated Hepatitis A Vaccine Price (US$/Unit) by Type (2019-2030)
Figure 53. Global Sales Market Share of Inactivated Hepatitis A Vaccine by Application (2019-2030)
Figure 54. Global Revenue Market Share of Inactivated Hepatitis A Vaccine by Application (2019-2030)
Figure 55. Global Inactivated Hepatitis A Vaccine Price (US$/Unit) by Application (2019-2030)
Figure 56. Inactivated Hepatitis A Vaccine Value Chain
Figure 57. Inactivated Hepatitis A Vaccine Production Process
Figure 58. Channels of Distribution (Direct Vs Distribution)
Figure 59. Distributors Profiles
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
